Citation Impact
Citing Papers
Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C
2007
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria
2012
Safety of Drotrecogin Alfa (Activated) in Surgical Patients with Severe Sepsis
2004
Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
2003
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
Immunomodulation in the critically ill
2009
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Acute kidney injury
2012 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an International Sepsis Registry
2009
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
Drotrecogin Alfa (Activated) in Adults with Septic Shock
2012 Standout
Management of Sepsis
2006
Host–pathogen interactions in sepsis
2007
Sepsis: pathophysiology and clinical management
2016
Sepsis and Septic Shock: A History
2009
Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo
2012 Standout
Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
2019
Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis
2007
Melioidosis
2012 Standout
Sepsis: a roadmap for future research
2015
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Inflammation and coagulation
2010
Severe Sepsis and Septic Shock
2013 Standout
Novel strategies for the treatment of sepsis
2003
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
2005
Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival
2009
The enigma of sepsis
2003
Early changes in organ function predict eventual survival in severe sepsis*
2005
Acute kidney injury
2019 Standout
Sepsis and septic shock
2018 Standout
Macrophage migration inhibitory factor: a regulator of innate immunity
2003 Standout
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis
2003
Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
2005
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Immunohaemostasis: a new view on haemostasis during sepsis
2017
Risks and Benefits of Activated Protein C Treatment for Severe Sepsis
2002
Host innate immune responses to sepsis
2013
Brazilian Sepsis Epidemiological Study (BASES study)
2004
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
2013 StandoutNobel
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*
2006 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Coagulation and sepsis
2016
Emerging drugs for the treatment of sepsis
2016
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety*
2006
Current treatment of severe sepsis
2006
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care
2018 Standout
Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines
2013
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
2009 Standout
Variation in critical care services across North America and Western Europe*
2008
Cardiovascular management of septic shock
2003
Incidence and Outcomes of Acute Lung Injury
2005 Standout
Prevalence and Significance of Coagulation Abnormalities in Community-Acquired Pneumonia
2009
The Epidemiology of Sepsis in the United States from 1979 through 2000
2003 Standout
The dark side of C5a in sepsis
2004
Extracellular histones are major mediators of death in sepsis
2009 Standout
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial*
2003
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
How I treat disseminated intravascular coagulation
2017
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering
2013
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
2003
Part 9: Post–Cardiac Arrest Care
2010 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
The cytoprotective protein C pathway
2006
The interactions between inflammation and coagulation
2005
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Protocolized Care for Early Septic Shock (ProCESS) statistical analysis plan.
2013
A Randomized Trial of Protocol-Based Care for Early Septic Shock
2014 Standout
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012
2014
Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
2019
The ADRENAL study protocol: ADjunctive corticosteroid tREatment iN criticAlly ilL patients with septic shock
2013
The Pathogenesis of Sepsis
2011
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation
2018
Part 14: Pediatric Advanced Life Support
2010 Standout
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
The enigma of sepsis
2003
Works of F. Schindel being referenced
Antithrombin III in patients with severe sepsis: a pharmacokinetic study
2000
Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin
2004
High-Dose Antithrombin III in Severe Sepsis
2001